2
|
19, and 33
|
--
|
Amenorrhea (6 and 8 months, respectively), galactorrhea, and presence of a proliferative endometrium
|
Total gonadotropin activity below the normal limits found in normal cycling women
|
Total gonadotropin activity below normal limits found in normal cycling women
|
--
|
--
|
Total estrogen activity below normal range found in normal cycling women
|
--
|
--
|
Distinctly elevated
|
--
|
Marked increase in LH and, to a lesser extent, FSH after GnRH
|
Marked increase in PRL and normal increase in TSH (basal levels of total T4, free T4 and thyroid binding globulins within normal range)
|
--
|
[52]
|
6
|
38.0 ± 2.5c
|
--
|
Amenorrhea and galactorrhea
|
Slightly elevated but within normal range
|
Within normal range
|
11.5
|
--
|
--
|
--
|
--
|
Markedly elevated
|
--
|
--
|
--
|
--
|
[53]
|
6
|
42.8 ± 6.3c
|
--
|
Amenorrhea without galactorrhea
|
Markedly elevated
|
Elevated
|
21.3
|
--
|
--
|
--
|
--
|
Within normal range
|
--
|
--
|
--
|
--
|
[53]
|
2
|
40 and 26
|
No treatment with tranquilizers in the past
|
Amenorrhea (3 and 7 months, respectively), galactorrhea, and recurrence of pseudocyesise
|
Normal
|
Normal
|
0.6 and 2.1
|
--
|
Within the follicular phase range
|
Within the follicular phase range
|
--
|
Within the normal range
|
--
|
Marked or normal increase in LH and normal increase in FSH after GnRH
|
Marked increase in PRL, normal increase in TSH and paradoxical increase in GH after TRH (normal basal levels of TSH and T4, and normal fasting blood glucose levels)
|
Blunted increase of GH (PRL was not measured) after apomorphinea in one woman and no response of GH and normal decrease in PRL after bromocriptinea in the other woman
|
[54]
|
1
|
16
|
--
|
Amenorrhea (5 months) without galactorrhea, and presence of a proliferative endometrium
|
Elevated (within the climacteric range)
|
Within the follicular phase range
|
2.9
|
--
|
Within the follicular phase range
|
Within the follicular phase range
|
--
|
Within the normal range
|
--
|
Normal increase in LH and FSH after GnRH; and normal positive feedback of LH after EB
|
Normal PRL and TSH increase after TRH (normal basal levels of TSH)
|
Normal increase in PRL after metoclopramideb
|
[55]
|
1
|
17
|
--
|
Amenorrhea (8 months) without galactorrhea, and the presence of a proliferative endometrium
|
Within the follicular phase range
|
Within the follicular phase range
|
0.9
|
--
|
Within the follicular phase range
|
Within the follicular phase range
|
--
|
Within the normal range
|
--
|
Normal increment in LH and FSH after GnRH, and normal positive feedback of LH after EB
|
Normal PRL and TSH increase after TRH (normal basal levels of TSH)
|
Normal increase of PRL after metoclopramideb
|
[55]
|
5
|
19-35 (median 22)
|
Women with a psychiatric condition that precluded informed consent were excluded
|
Amenorrhea (5.5-12.5 months), galactorrhea (3 women), and hirsutism (3 women, one of them with clitoromegaly)
|
Below the upper normal limit (<20 IU/L) with either low-normal or definitely low pulse amplitudes (early-follicular phase)
|
Within the follicular phase range
|
1.2
|
Elevated in 3 women. Another women with mildly elevated FAIf
|
Within the early-follicular range
|
Within the early-follicular range.
|
--
|
Normal levels with greater release during sleep than during daytime (1 women displayed high PRL levels)
|
--
|
--
|
--
|
--
|
[56]
|
9
|
24.9 ± 2.2d
|
--
|
Amenorrhea (3–12 months) and galactorrhea (8 women)
|
Within the follicular phase range
|
Within the follicular phase range
|
1.1
|
--
|
6 women with lower levels than the follicular phase range
|
2 women with luteal phase levels
|
5 women exhibited impaired GH responses to hypoglycemia (4 of them also displayed E2 deficiency)
|
Within follicular phase range
|
Normal responses of cortisol to hypoglycemia (peak responses exceeded 600 nmol/L)
|
4 women with exaggerated LH response (2 of them also with exaggerated FSH response) after GnRH
|
Normal PRL and TSH increase after TRH (1, 1 and 2 women had exaggerated PRL, GH and TSH responses, respectively)
|
Decrease in PRL. In 4 women, no increase in GH after L-DOPAa (3 of these women displayed also impaired GH response to hypoglycemia)
|
[57]
|